Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lancaster

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of the Society for Gynecologic Investigation|October 17, 1998
Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancersM E Carney, G L Maxwell, J M Lancaster, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Gynecologic Oncology|June 30, 2007
Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosisM A Martino, E Williamson, L Rajaram, et al.
Journal of the National Cancer Institute|April 17, 1996
Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation testJ M Lancaster, C J Cochran, H A Brownlee, et al.
British Medical Journal|November 4, 1978
Private practice and the reduction of pay-bedsJ J Shipman, K W Giles, A R Ryan, et al.
Gynecologic Oncology|June 28, 2001
Allele loss on chromosome 1p36 in epithelial ovarian cancersA A Alvarez, A R Lambers, J M Lancaster, et al.
Southern Medical Journal|January 1, 1988
Pathologic fractures of the humerusJ M Lancaster, L A Koman, A G Gristina, et al.
In Vivo (Athens, Greece)|March 16, 2007
Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapyA Nasir, D Boulware, H E Kaiser, et al.
Molecular Carcinogenesis|November 1, 1996
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancerJ M Lancaster, H A Brownlee, D A Bell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 4, 2006
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levelsJ M Lancaster, R A Sayer, C Blanchette, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of the Society for Gynecologic Investigation|October 17, 1998
Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancersM E Carney, G L Maxwell, J M Lancaster, et al.
American Journal of Obstetrics and Gynecology|September 1, 1996
Role of BRCA1 mutation screening in the management of familial ovarian cancerA Berchuck, F Cirisano, J M Lancaster, et al.
Gynecologic Oncology|June 30, 2007
Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosisM A Martino, E Williamson, L Rajaram, et al.
Journal of the National Cancer Institute|April 17, 1996
Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation testJ M Lancaster, C J Cochran, H A Brownlee, et al.
British Medical Journal|November 4, 1978
Private practice and the reduction of pay-bedsJ J Shipman, K W Giles, A R Ryan, et al.
Gynecologic Oncology|June 28, 2001
Allele loss on chromosome 1p36 in epithelial ovarian cancersA A Alvarez, A R Lambers, J M Lancaster, et al.
Southern Medical Journal|January 1, 1988
Pathologic fractures of the humerusJ M Lancaster, L A Koman, A G Gristina, et al.
In Vivo (Athens, Greece)|March 16, 2007
Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapyA Nasir, D Boulware, H E Kaiser, et al.
Molecular Carcinogenesis|November 1, 1996
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancerJ M Lancaster, H A Brownlee, D A Bell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 4, 2006
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levelsJ M Lancaster, R A Sayer, C Blanchette, et al.
Pageof 3